Find out more about how this website uses cookies to enhance your browsing experience.
MLS® Class IV Therapeutic Laser - Mphi 75.5
Mphi 75.5 (multi-diode)
Mphi 75.5, is the complete solution, and includes multi diode applicator and standard handpiece. The multi diode applicator has a large 5cm diameter target area, which makes it possible to easily treat large areas of muscle, or whole joints.
The multi diode applicator can be programmed to complete treatment without constant operator assistance. The multi diode applicator and standard handpiece can be used simultaneously, allowing multiple areas of the body to be treated in one session.
The patented MLS® system delivers pulsed and continuous laser emissions synchronised for the optimal therapeutic effect with wavelengths of 808nm and 905nm. The advanced MLS® laser technology allows true pulsed emissions to achieve peak power of 75 watts, without the risk of thermal damage.
- Osteoarthritis
- Back pain
- Bursitis
- Cervical brachialgia
- Craniofacial pain
- Oedema
- Haematoma
- Joint pain
- Plantar fasciitis
- Sprains
- Strains
- Tendonitis
- Trauma
- Ulcers
- Wounds
- Many indications
- 75W peak power
- Charlie applicator able to treat a large target area
- Simultaneous use of the Charlie applicator and regular handpiece to treat multiple areas
- Simultaneous therapeutic action - analgesic, anti-inflammatory, anti-oedema
- MLS Pulsed combination-synchronisation - 905nm pulsed emissions & 808nm continuous emissions - ensure deep penetration
- Fast treamtnet times - from 3-10 minutes
- Reduced number of applications - notable reduction of symptoms from the first session
Technical characteristics
- 3 MLS® laser sources, power up to 3.6 W - Peak Power 75W in the CHARLIE multidiode applicator
- MLS® laser source with handpiece power up to 1.2W - Peak Power 75W
- MLS® modulation in CPW and FPW
- MLS® impulse modulation frequency from 1 to 2000 Hz in steps of 1Hz
- 25%, 50%, 75% and 100% power levels
- Fixed or variable duty cycle
- Treatment time from 1” to 99’59” in steps of 1”
- CHARLIE multidiode applicator with Target Area Ø 5 cm highlighted by high efficiency red LEDs
- Handpiece with Ø 2 cm Target Area highlighted by high efficiency red LEDs
- Instrument trolley with pantograph arm
- User interface based on a backlit colour touchscreen monitor
- User-friendly management software
- Contemporary management of two independent channels
- 4 treatment modes:
A) specific pathologies B) pain treatment C) anti-oedema D) biostimulation - Personalizable treatment parameters
- Automatic calculation of the issued energy according to set parameters
Supplied accessories and safety alarms
- Laser emission warning light
- Interlock
- Audible alarm that can be set by the operator
- Date and time functions
- Password for device starting
- Language change
- Possibility of connecting a Laser emission signal repeater
Included accessories
- N° 2 Laser Safety Goggles
- Unit carrying case
- Table handpiece holder
- Shoulder strap for portable use
- Trolley-Ergonomic trolley designed for holding Mphi, with bumper-protected wheels, a built-in handpiece holder and two storage compartments
Size and weight
63 x 54 x 85 cm; 25 kg
Power supply
- Lithium polymer battery
- External power supply 18V‗ 50VA
Each year the ASAcampus (an association between ASAlaser and The University of Florence) publish 'Energy for Health', a scientific magazine focusing on the results of research and clinical studies carried out by internationally renowned researchers, doctors and specialists both in Italy and abroad.
Chow RT, David MA, Armati PJ. 830 nm laser irradiation induces varicosity formation, reduces mitochondrial membrane potential and blocks fast axonal flow in small and medium diameter rat dorsal root ganglion neurons: implications for the analgesic effects of 830 nm laser. J Peripher Nerv Syst. 2007 Mar;12(1):28-39.
Simunovic Z. Low level laser therapy with trigger points technique: a clinical study on 243 patients. J Clin Laser Med Surg. 1996 Aug;14(4):163-7.
Bjordal JM, Lopes-Martins RA, Iversen VV. A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br J Sports Med. 2006 Jan;40(1):76-80; discussion 76-80.
Xavier M, David DR, de Souza RA, Arrieiro AN, Miranda H, Santana ET, Silva JA Jr, Salgado MA, Aimbire F, Albertini R. Anti-inflammatory effects of low-level light emitting diode therapy on Achilles tendinitis in rats. Lasers Surg Med. 2010 Aug;42(6):553-8.
Albertini R, Aimbire F, Villaverde AB, Silva JA Jr, Costa MS. COX-2 mRNA expression decreases in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low level laser therapy. Inflamm Res. 2007 Jun;56(6):228-9.
Kajagar BM, Godhi AS, Pandit A, Khatri S. Efficacy of low level laser therapy on wound healing in patients with chronic diabetic foot ulcers-a randomised control trial. Indian J Surg. 2012 Oct;74(5):359-63.
Baxter GD, Liu L, Petrich S, Gisselman AS, Chapple C, Anders JJ, Tumilty S. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review. BMC Cancer. 2017 Dec 7;17(1):833.
Wigg, J. Use and response to treatment using low lovel laser therapy. Journal of Lymphoedema, 2009, Vol 4, No 2.
Medrado AR, Pugliese LS, Reis SR, Andrade ZA. Influence of low level laser therapy on wound healing and its biological action upon myofibroblasts. Lasers Surg Med. 2003;32(3):239-44.
Fabre HS, Navarro RL, Oltramari-Navarro PV, Oliveira RF, Pires-Oliveira DA, Andraus RA, Fuirini N, Fernandes KB. Anti-inflammatory and analgesic effects of low-level laser therapy on the postoperative healing process. J Phys Ther Sci. 2015 Jun;27(6):1645-1648.
Artés-Ribas M, Arnabat-Dominguez J, Puigdollers A. Analgesic effect of a low-level laser therapy (830 nm) in early orthodontic treatment. Lasers Med Sci. 2013 Jan;28(1):335-41.
Wang P, Liu C, Yang X, Zhou Y, Wei X, Ji Q, Yang L, He C. Effects of low-level laser therapy on joint pain, synovitis, anabolic, and catabolic factors in a progressive osteoarthritis rabbit model. Lasers Med Sci. 2014 Nov;29(6):1875-85.
Prianti AC Jr, Silva JA Jr, Dos Santos RF, Rosseti IB, Costa MS. Low-level laser therapy (LLLT) reduces the COX-2 mRNA expression in both subplantar and total brain tissues in the model of peripheral inflammation induced by administration of carrageenan. Lasers Med Sci. 2014 Jul;29(4):1397-403.
Guerra Fda R, Vieira CP, dos Santos de Almeida M, Oliveira LP, Claro AC, Simões GF, de Oliveira AL, Pimentel ER. Pulsed LLLT improves tendon healing in rats: a biochemical, organizational, and functional evaluation. Lasers Med Sci. 2014 Mar;29(2):805-11.
Training and CPD
All laser purchases come with training to enable you to maximise your clinical results from laser use.
Servicing
All our units require regular servicing, our dedicated team of engineers are able to service units at a time convenient for you to ensure your machine remains in top condition.
Free Trial
Celtic SMR is offering free demonstrations and trials of the ASA Laser so please call us on 0800 279 9050 to find out more.